Topical 2% Povidone-Iodine Gel in Verruca Vulgaris

Inclusion Criteria: * Subject is able to comprehend and is willing to sign an informed consent/assent for participation in this study. * Male or female ≥ 8 years old. * Subject has a clinical diagnosis of verruca vulgaris (common warts). * Subject has up to 6 warts located on the trunk or extremities Exclusion Criteria: * Subject has clinically atypical warts on the trunk or extremities. * Subject is immunocompromised (e.g., due to chemotherapy, systemic steroids, genetic immunodeficiency, transplant status, etc.) * Subject has periungual, subungual, genital, anal, mosaic, plantar, flat, or filiform wart identified as a wart for study treatment.